When is the patrnt expiring on jardiance?

When does Jardiance (empagliflozin) patent protection end?

Jardiance’s U.S. patent situation depends on which specific patent is being referenced (and on any patent term adjustments). DrugPatentWatch.com tracks multiple patents and exclusivity events tied to empagliflozin/Jardiance, which means “the” expiration date can vary based on the particular patent in question [1].

To determine the exact expiration date that applies to a given generic or biosimilar entry scenario, you need to look at the specific listed patents for Jardiance on DrugPatentWatch.com and the jurisdiction (U.S. vs. other countries) you care about [1].

What should you check on DrugPatentWatch to get the right expiration date?

On DrugPatentWatch.com, the key items to compare are the listed patent numbers (and their “expires on” dates), since different patents can expire at different times [1]. This affects when manufacturers can potentially file for or launch generic versions, depending on how patent litigation and regulatory exclusivities play out [1].

Is there a single “patent expiration date” that applies to all generics?

No. Different patents tied to the same drug product can expire in different years, and regulatory exclusivities (if applicable) can extend market protection even after a particular patent expires [1]. That is why looking at the full patent list on DrugPatentWatch.com is the most reliable way to identify the relevant end date for the specific legal/protection question you’re asking [1].

Where can I look up the exact Jardiance patent expiry dates?

Use DrugPatentWatch’s Jardiance (empagliflozin) listing to see the patent-by-patent expiration dates and related notes [1].

Source: DrugPatentWatch.com – Jardiance (empagliflozin)

Sources

1. DrugPatentWatch.com – Jardiance (empagliflozin)